Log in or Sign up for Free to view tailored content for your specialty!
Retina/Vitreous News
VIDEO: Ask patients about impact of thyroid eye disease on quality of life
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Lisa M. Nijm, MD, JD, discusses the burden of thyroid eye disease and how it affects quality of life.
FDA clears investigational new drug application for photoreceptor disease therapy
The FDA cleared an investigational new drug application for OpCT-001, an investigational cell therapy for the treatment of primary photoreceptor diseases, according to a press release from BlueRock Therapeutics.
Log in or Sign up for Free to view tailored content for your specialty!
Tepezza linked with promising re-treatment rates for thyroid eye disease
Less than 25% of patients with thyroid eye disease who underwent a full course of treatment with Tepezza required re-treatment, according to a study published in Ophthalmology.
Severe COVID-19 may impact retina
Retinal ganglion cell layer thickness was significantly reduced in patients with severe COVID-19, which indicates an affinity for nerve cells, according to research published in the Open Journal of Ophthalmology.
Delayed diagnosis of congenital optic disc abnormalities may worsen visual prognosis
Delayed diagnosis of congenital optic disc abnormalities increases the risk for complications and may affect visual prognosis, according to a study published in the Open Journal of Ophthalmology.
Deep-learning model based on retinal images may help assess cardiovascular disease risk
The retinal image-based, deep-learning cardiac BioAge model accurately stratified individuals by traditional cardiovascular disease risk biomarkers, with leukocyte telomere length inversely related to BioAge score, researchers reported.
Participant visits complete in phase 2b trial of CLS-AX for wet AMD
Clearside Biomedical announced the completion of the final participant visit in its ODYSSEY phase 2b clinical trial of CLS-AX, an axitinib injectable suspension for neovascular age-related macular degeneration.
Enrollment, dosing complete in phase 1 trial of AIV007 for AMD, diabetic macular edema
AiViva Biopharma announced that it has completed enrollment and dosing of the last patient in a phase 1 clinical trial of AIV007 for wet age-related macular degeneration and diabetic macular edema.
VIDEO: Eye6 smart glasses improve vision in patients with AMD
CARLSBAD, Calif. — In this Healio Video Perspective from the Women in Ophthalmology Summer Symposium, Kelley Sheets of Eyedaptic gives an overview of the Eye6 wearable vision aid for patients with age-related macular degeneration.
FDA grants rare pediatric disease designation for Leber congenital amaurosis gene therapy
Opus Genetics received rare pediatric disease designation from the FDA for its ocular gene therapy designed to treat patients with a form of Leber congenital amaurosis, according to a press release.
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read
-
Headline News
Study: Young patients hesitant to tell providers information their parents might see
November 06, 20242 min read -
Headline News
Q&A: Adults may know their risk for COPD with blood test
November 07, 20243 min read -
Headline News
CMS increases payment for dialysis facilities, includes oral-only drugs in the bundle
November 08, 20242 min read